Work

Standard and Targeted Biopsy During Follow-up for Active Surveillance.

Year: 2015

Type: article

Abstract: Many patients diagnosed with prostate cancer have low-risk disease that is unlikely to harm them during their lifetimes. Active surveillance (AS) has emerged as a crucial treatment option for patients with favorable-risk prostate cancer. Although its use continues to expand globally, there remains a lack of consensus on the optimal follow-up strategy.1 Many studies have evaluated predictors of progression during AS in an effort to provide insight into the appropriate timing of repeat prostate biopsy.2 Some AS programs incorporate a confirmatory biopsy because early reclassification often represents sampling error from the initial biopsy.3 A relatively new addition to AS is the use of MRI-targeted biopsy (MRI-TB).

Source: PubMed Central

DOI: 10.3909/riu0670a

Authors: Brian Weiss, Stacy Loeb

Institutions: NYU Langone Health, New York University

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute